Avalo Therapeutics, Inc.
Recent Filings
All 1,001 filings →Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| Goldman Jonathan | — | Sale | 3,167 @ $14.30 | — | Nov 14, 2025 |
| Almenoff June Sherie | — | Purchase | 500 @ $13.00 | 1,000 | Nov 12, 2024 |
| Armistice Capital Master Fund Ltd. | — | Sale | 2,746,138 @ $0.61 | 1,668,862 | Jun 27, 2023 |
| Caissa Capital Management ltd. | — | Purchase | 182,300 @ $0.62 | — | Jun 26, 2023 |
| Caissa Capital Management ltd. | — | Purchase | 2,000 @ $4.14 | 1,425,700 | Jun 15, 2023 |
| Caissa Capital Management ltd. | — | Purchase | 8,750 @ $3.82 | 1,411,540 | Jun 14, 2023 |
| Caissa Capital Management ltd. | — | Purchase | 6,398 @ $3.93 | 1,395,597 | Jun 9, 2023 |
| Sullivan Christopher Ryan | Chief Financial Officer | Purchase | 511 @ $3.42 | 1,262 | Jun 9, 2023 |
| NEIL GARRY ARTHUR | CEO and Chairman of the Board | Purchase | 4,000 @ $3.42 | 13,220 | Jun 9, 2023 |
| Caissa Capital Management ltd. | — | Purchase | 844 @ $2.87 | 1,386,215 | May 31, 2023 |